<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain><z:hpo ids='HP_0002863'>Myelodysplastic syndromes</z:hpo> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e>) and myeloproliferative syndromes (MPS) of childhood are a <z:hpo ids='HP_0001425'>heterogeneous</z:hpo> group of clonal disorders of hematopoiesis with overlapping clinical features and inconsistent nomenclature </plain></SENT>
<SENT sid="1" pm="."><plain>Although a number of <z:e sem="disease" ids="C0019247" disease_type="Disease or Syndrome" abbrv="">genetic conditions</z:e> have been associated with <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e> and MPS, the overall contribution of inherited predispositions is uncertain </plain></SENT>
<SENT sid="2" pm="."><plain>We report a retrospective study examining clinical features, genetic associations, and outcomes in 167 children with <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e> and MPS </plain></SENT>
<SENT sid="3" pm="."><plain>Of these patients, 48 had an associated constitutional disorder </plain></SENT>
<SENT sid="4" pm="."><plain>One hundred one patients had adult-type <z:hpo ids='HP_0002863'>myelodysplastic syndrome</z:hpo> (A-<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e>), 60 had juvenile myelomonocytic <z:hpo ids='HP_0001909'>leukemia</z:hpo> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">JMML</z:e>), and 6 infants with <z:e sem="disease" ids="C0013080" disease_type="Disease or Syndrome;Congenital Abnormality" abbrv="">Down syndrome</z:e> had a <z:hpo ids='HP_0005534'>transient myeloproliferative syndrome</z:hpo> (TMS) </plain></SENT>
<SENT sid="5" pm="."><plain><z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">JMML</z:e> was characterized by young age at <z:hpo ids='HP_0003674'>onset</z:hpo> and prominent <z:hpo ids='HP_0001433'>hepatosplenomegaly</z:hpo>, whereas patients with A-<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e> were older and had little or no organomegaly </plain></SENT>
<SENT sid="6" pm="."><plain>The most common cytogenetic abnormalities were <z:mp ids='MP_0004026'>monosomy</z:mp> 7 or del(7q) (53 cases); this was common both in patients with <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">JMML</z:e> and those with A-<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e> </plain></SENT>
<SENT sid="7" pm="."><plain>Leukemic transformation was observed in 32% of patients, usually within 2 years of diagnosis </plain></SENT>
<SENT sid="8" pm="."><plain>Survival was 25% at 16 years </plain></SENT>
<SENT sid="9" pm="."><plain>Favorable prognostic features at diagnosis included age less than 2 years and a <z:chebi fb="0" ids="35143">hemoglobin</z:chebi> F level of less than 10% </plain></SENT>
<SENT sid="10" pm="."><plain>Older patients tended to present with an adult-type <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e> that is accommodated within the French-American-British system </plain></SENT>
<SENT sid="11" pm="."><plain>In contrast, infants and young children typically developed unique disorders with overlapping features of <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e> and MPS </plain></SENT>
<SENT sid="12" pm="."><plain>Although the type and intensity of therapy varied markedly in this study, the overall outcome was poor except in patients with TMS </plain></SENT>
</text></document>